Voloridge Investment Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-209,355
| Closed | -$15.8M | – | 1684 |
|
|
2022
Q2 | $15.8M | Buy |
209,355
+3,608
| +2% | +$272K | 0.08% | 322 |
|
|
2022
Q1 | $5.52M | Buy |
205,747
+58,795
| +40% | +$1.58M | 0.03% | 603 |
|
|
2021
Q4 | $7.01M | Buy |
146,952
+81,668
| +125% | +$3.9M | 0.04% | 587 |
|
|
2021
Q3 | $4.34M | Sell |
65,284
-36,725
| -36% | -$2.44M | 0.03% | 736 |
|
|
2021
Q2 | $7.96M | Buy |
102,009
+74,394
| +269% | +$5.8M | 0.06% | 479 |
|
|
2021
Q1 | $2.61M | Buy |
27,615
+20,737
| +301% | +$1.96M | 0.02% | 726 |
|
|
2020
Q4 | $838K | Sell |
6,878
-52,481
| -88% | -$6.39M | 0.01% | 1017 |
|
|
2020
Q3 | $5.19M | Buy |
+59,359
| New | +$5.19M | 0.04% | 432 |
|
|
2020
Q1 | – | Sell |
-15,478
| Closed | -$964K | – | 1496 |
|
|
2019
Q4 | $964K | Buy |
+15,478
| New | +$964K | 0.02% | 662 |
|